FDA finally pulls permission for J&J COVID shots!

Photo courtesy Johnson & Johnson
Photo courtesy Johnson & Johnson

Linked to serious blood clots, bleeding threats

Bob Unruh
WND News Center

Pfizer, Moderna and Johnson & Johnson were the main suppliers of those experimental COVID shots allowed by the Food and Drug Administration during the pandemic that apparently came out of a Chinese lab in Wuhan.

Since the number of deaths directly caused by the virus has dropped, there has been a long list of side effects and complications that have appeared, offering significant health threats to many.

But now an even worse problem has appeared, and the FDA has withdrawn permission for the J&J shots to be used.

According to a report in the Daily Mail, some 19 million Americans took that particular shot.

But one of the complications it apparently triggered was a condition involving blood clots.

The report said the cancellation of permission for the shots to be used was not a surprise, because the parent company, Jannsen, had asked for the move following revelations that the last run of doses, more than 12 million, expired.

Estimates are that some 231 million Americans were subjected, often on governmental or corporate mandates, to a shot from one of the three production companies.

The value of all of them also has been questioned, as one study revealed that the more shots and boosters patients took, the more likely they were to come down with COVID.

J&J’s decision appears to indicate that it is stepping away from the COVID vaccination market entirely.

The report noted Peter Marks, of the FDA’s Center for Biologics Evaluation and Research, announced, “Because FDA understands that… Janssen Biotech, Inc. has requested that FDA withdraw the EUA for the Janssen COVID-19 Vaccine, FDA has determined that it is appropriate to protect the public health or safety to revoke this authorization.”

Johnson & Johnson’s product was dispatched for use on Americans in February 2021, well after mRNA shots by the other two companies had been available.

It then took only a month from the time the “emergency” authorization was granted that the shots were mired in word of a surging number of severe blood clotting problems.

Doctors identified those as thrombosis with thrombocytopenia syndrome.

That involves blood clots complicated by a severely low platelet count that prevents the body from stopping bleeding.

The FDA and Centers for Disease Control earlier mandated a “pause” on the use of the shots.

They later claimed it was “safe and effective.”

Also read:

Leave a Reply

Your email address will not be published. Required fields are marked *